Nanotechnology for Targeted Therapy of Atherosclerosis.
| Autor: | Hossaini Nasr S; Department of Chemistry, Michigan State University, East Lansing, MI, United States.; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States., Huang X; Department of Chemistry, Michigan State University, East Lansing, MI, United States.; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States.; Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in pharmacology [Front Pharmacol] 2021 Nov 12; Vol. 12, pp. 755569. Date of Electronic Publication: 2021 Nov 12 (Print Publication: 2021). |
| DOI: | 10.3389/fphar.2021.755569 |
| Abstrakt: | Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with therapeutic effects on atherosclerotic plaques known as atheroprotective nanomedicine have been summarized to stimulate further development and future translation. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Hossaini Nasr and Huang.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|